Dr. Alan Lichtenstein and his colleagues are studying the molecular biology of multiple myeloma, chronic lymphocytic leukemia and squamous cell cancer of the head and neck. Their studies are directed at identifying molecules that are particularly abnormal in these diseases so that they can be targeted with novel forms of therapy. The research involves in vitro experimentation on tumor cells, studies of tumor growth in mice and clinical studies in patients with these diseases.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811